학술논문

How to choose between curative radiotherapy or chemotherapy in low stage MCL?—a population‐based analysis of outcome in patients with stage I‐II MCL in Sweden.
Document Type
Article
Source
Hematological Oncology; Jun2023 Supplement 1, Vol. 41, p476-477, 2p
Subject
RADIOTHERAPY
PROGRESSION-free survival
CANCER chemotherapy
Language
ISSN
02780232
Abstract
Copyright of Hematological Oncology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)